NovoCure Ltd (NVCR) stock
NVCRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/3027% below fair value
$11.83+0.11 (+0.94%)
Close on Nov 13, 2026Market cap $1.38BP/E –Yield –
NovoCure gross margin
Gross margin is gross profit as a percentage of revenue.
NovoCure's gross margin for the twelve months ending Sep 30, 2026 was 77.0%. For fiscal 2025 it was 74.5%, against 77.3% the year before. The highest annual figure on record is 78.6% in fiscal 2022.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 74.5% | −2.8 |
| FY2024 | Dec 31, 2024 | 77.3% | +2.5 |
| FY2023 | Dec 31, 2023 | 74.8% | −3.8 |
| FY2022 | Dec 31, 2022 | 78.6% | +0.1 |
| FY2021 | Dec 31, 2021 | 78.5% | +0.1 |
| FY2020 | Dec 31, 2020 | 78.5% | +3.7 |
| FY2019 | Dec 31, 2019 | 74.8% | +7.0 |
| FY2018 | Dec 31, 2018 | 67.7% | −0.9 |
| FY2017 | Dec 31, 2017 | 68.6% | +24.4 |
| FY2016 | Dec 31, 2016 | 44.2% | +6.5 |
| FY2015 | Dec 31, 2015 | 37.7% | +2.5 |
| FY2014 | Dec 31, 2014 | 35.2% | +2.9 |
| FY2013 | Dec 31, 2013 | 32.3% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 77.0% | +3.7 |
| Q2 FY2026 | Jun 30, 2026 | 77.6% | +3.7 |
| Q1 FY2026 | Mar 31, 2026 | 77.6% | +2.5 |
| Q4 FY2025 | Dec 31, 2025 | 75.8% | −3.4 |
| Q3 FY2025 | Sep 30, 2025 | 73.2% | −3.9 |
| Q2 FY2025 | Jun 30, 2025 | 73.9% | −3.1 |
| Q1 FY2025 | Mar 31, 2025 | 75.1% | −0.5 |
| Q4 FY2024 | Dec 31, 2024 | 79.2% | +3.6 |
| Q3 FY2024 | Sep 30, 2024 | 77.2% | +2.4 |
| Q2 FY2024 | Jun 30, 2024 | 77.0% | +3.9 |
| Q1 FY2024 | Mar 31, 2024 | 75.7% | −0.1 |
| Q4 FY2023 | Dec 31, 2023 | 75.7% | −1.8 |
| Q3 FY2023 | Sep 30, 2023 | 74.8% | −2.5 |
| Q2 FY2023 | Jun 30, 2023 | 73.0% | −6.8 |
| Q1 FY2023 | Mar 31, 2023 | 75.8% | −4.1 |
| Q4 FY2022 | Dec 31, 2022 | 77.5% | −0.2 |
| Q3 FY2022 | Sep 30, 2022 | 77.3% | −0.1 |
| Q2 FY2022 | Jun 30, 2022 | 79.8% | +1.2 |
| Q1 FY2022 | Mar 31, 2022 | 79.8% | −0.6 |
| Q4 FY2021 | Dec 31, 2021 | 77.7% | −2.7 |
| Q3 FY2021 | Sep 30, 2021 | 77.4% | −1.2 |
| Q2 FY2021 | Jun 30, 2021 | 78.6% | +0.6 |
| Q1 FY2021 | Mar 31, 2021 | 80.4% | +4.5 |
| Q4 FY2020 | Dec 31, 2020 | 80.5% | +5.4 |
| Q3 FY2020 | Sep 30, 2020 | 78.6% | +3.5 |
| Q2 FY2020 | Jun 30, 2020 | 78.0% | +2.4 |
| Q1 FY2020 | Mar 31, 2020 | 75.9% | +3.0 |
| Q4 FY2019 | Dec 31, 2019 | 75.0% | +8.1 |
| Q3 FY2019 | Sep 30, 2019 | 75.1% | +4.4 |
| Q2 FY2019 | Jun 30, 2019 | 75.7% | +7.9 |
| Q1 FY2019 | Mar 31, 2019 | 73.0% | +8.0 |
| Q4 FY2018 | Dec 31, 2018 | 66.9% | −3.9 |
| Q3 FY2018 | Sep 30, 2018 | 70.7% | +1.0 |
| Q2 FY2018 | Jun 30, 2018 | 67.8% | +2.0 |
| Q1 FY2018 | Mar 31, 2018 | 65.0% | −1.5 |
| Q4 FY2017 | Dec 31, 2017 | 70.9% | +7.1 |
| Q3 FY2017 | Sep 30, 2017 | 69.8% | – |
| Q2 FY2017 | Jun 30, 2017 | 65.7% | – |
| Q1 FY2017 | Mar 31, 2017 | 66.6% | – |
| Q4 FY2016 | Dec 31, 2016 | 63.7% | – |
See a number that looks wrong?